Depakote Tablet, Delayed Release
Product Images NDC 0074-7327

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 0074-7327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structure Divalproex Sodium Is A Stable Co-ordination Compound Comprised Of Sodium Valproate And Valproic Acid In A 1:1 Molar Relationship And Formed During The Partial Neutralization Of Valproic Acid With 0.5 Equivalent Of Sodium Hydroxide. Chemically It Is Designated As Sodium Hydrogen Bis(2-propylpentanoate). (Depakote Tablets Spl 01)

FDA Label Image

Figure 1 (Depakote Tablets Spl 02)

FDA Label Image

Figure 2 (Depakote Tablets Spl 03)

FDA Label Image

Figure 3 (Depakote Tablets Spl 04)

FDA Label Image

Figure 4 (Depakote Tablets Spl 05)

FDA Label Image

Ndc 0074-6212-13 100 Tablets Depakote®divalproex Sodium Delayed-release Tablets 125 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Depakote Tablets Spl 06)

This is a description of a medication called Depakote, which comes in a bottle of 100 delayed-release tablets. The active ingredient is valproex sodium. The rest of the text is mostly product information such as the NDC number, the manufacturer's contact information, and instructions to consult a guide before use. The text does not provide any information on the purpose, usage, or potential side effects of the medication.*

FDA Label Image

Ndc 0074-6214-53 500 Tablets Depakote®divalproex Sodium Delayed-release Tablets 250 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient Rx Only Abbvie (Depakote Tablets Spl 07)

This is a prescription drug label for Divalproex Sodium Delayed-Release Tablets with NDC number 0074-7325-13. It contains 100 tablets and has a barcode. The label recommends dispensing the medication guide accompanying the tablets to each patient. The expiration date is not available.*

FDA Label Image

Ndc 0074-6214-13 100 Tablets Depakote®divalproex Sodium Delayed-release Tablets 250 mg Valproic Acid Activity Do Not Accept If Seal Over Bottle Opening Is Broken Or Missing. Dispense The Accompanying Medication Guide To Each Patient.rx Only Abbvie (Depakote Tablets Spl 08)

This is a description of a medication called DEPAKOTE® in the form of delayed-release tablets. The tablets are 250 mg and contain DIVALPROEX SODIUM. The prescription for the medication is only available with a valid Rx.*

FDA Label Image

Ndc 0074-6215-13 100 Tablets Depakote®divalproex Sodium Delayed-release Tablets 500 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Depakote Tablets Spl 09)

This is a description of a medication called Valproic Acid. It comes in the form of 500 mg tablets, manufactured by AbbVie LTD. The accompanying Medication Guide must be dispersed to the patient. The prescription can only be dispensed with an Rx. The rest of the text is not available due to errors.*

FDA Label Image

Depakote Tablets Spl 0a

This text provides information regarding a medication called Divalproex Sodium, available in a delayed-release tablet form. The medication has an NDC code of 0074-7327-13 and is packaged with 100 tablets per container. The given text also mentions a 2D barcode and instructions to dispense the medication with the accompanying Medication Guide to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.